Title:
MEDICINAL COMPOSITION FOR TREATING HUMAN PROSTATIC ADENOCARCINOMA
Document Type and Number:
Japanese Patent JP2002308776
Kind Code:
A
Abstract:
To provide a medicinal composition useful in the therapy for human prostatic adenocarcinoma.
The medical composition for treating human prostatic adenocarcinoma contains a 5-α-reductase inhibiting compound such as 17β-(N-t- butylcarboxyamido)-5-α-androst-1-ene-4-aza-3-one and a pharmaceutically permissible carrier.
Inventors:
JOHNSON RANDALL K
Application Number:
JP2002065181A
Publication Date:
October 23, 2002
Filing Date:
June 21, 1991
Export Citation:
Assignee:
SMITHKLINE BEECHAM CORP
International Classes:
A61K31/56; A61K31/565; A61K31/57; A61K31/58; A61K45/00; A61P5/28; A61P13/02; A61P13/08; A61K31/568; A61P15/00; A61P35/00; A61P43/00; C07J1/00; C07J5/00; C07J31/00; C07J41/00; C07J51/00; C07J73/00; (IPC1-7): A61K31/568; A61K31/58; A61P13/08; A61P35/00; A61P43/00; C07J41/00; C07J73/00
Attorney, Agent or Firm:
Aoyama Ryo (2 outside people)
Previous Patent: EXTERNAL COMPOSITION
Next Patent: COMPOSITION HAVING VASCULARIZATION INHIBITORY EFFECT
Next Patent: COMPOSITION HAVING VASCULARIZATION INHIBITORY EFFECT